March's Trade News Digest

15 March 2020


Thermo Fisher Acquires Qiagen NV

After lengthy discussions and a lot of back and forth, Thermo Fisher and Qiagen NV have finally agreed an acquisition deal for $11.5bn.

Thermo Fisher hopes to expand their molecular diagnostics and sample preparation technologies with the acquisition of the global company.

“We are excited to bring together our complementary offerings to advance our customers’ important work, from discovery to diagnostics,” said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher Scientific.

“This acquisition provides us with the opportunity to leverage our industry-leading capabilities and R&D expertise to accelerate innovation and address emerging healthcare needs. For shareholders, we expect the transaction to be immediately accretive and to generate significant cost and revenue synergies.”

Alphatec Acquires EOS Imaging

Medical Device spinal specialist Alphatec Holdings (ATEC) has announced it has agreed to purchase EOS imaging for up to $88 million, plus debt retirement of $33.9 million, in a combination of cash and equity.

The imaging company is a leader in orthopaedic medical imaging solutions and renowned for its rapid, low dose, full-body imaging and 3D technologies.

CEO for ATEC, Pat Miles said “This is a monumental transaction for ATEC. While spine’s large players are investing in enabling technologies, we are thinking differently. We created a conduit to deliver information into the operating room with AlphaInformatiX.

This transaction will integrate spine imaging and anatomical modeling onto the platform to actually inform the operative experience. By pairing ATEC’s approach-based solutions with imaging founded on Nobel Prize-winning technology, we expect to significantly increase demand for ATEC hardware and EOS systems and create a formidable competitive advantage.”

Inomec Acquired by Integer

Integer Holdings has announced it has acquired medical device company, Inomec.

The deal will expand Integer's portfoilio for products to catheter design, clinical, and pilot manufacturing capabilities.

“Acquiring Inomec strengthens our research and development pipeline by adding differentiated capabilities and expanding our global footprint in a key market with an extensive innovation ecosystem that is widely recognized as a leader in MedTech innovation.” Integer president and CEO Joe Dziedzic said.

Invacare sells Dynamic Controls to Allied Motion

Invacare Corporation has announced it has completed the sale of its subsidiary, Dynamic Controls, to miniature and medium-power motion control system specialist, Allied Motion.

The agreement is to include a long term supply deal for Invacare to offer ongoing support of the LiNX wheelchair system and MyLinx informatics platform.

“As so much of our business is based on electromotive propulsion, we are pleased to be working more closely with a leading innovator of motion technology to pave the way for better-integrated propulsion systems in the future. By entering into a strategic relationship with Allied Motion, we can create exciting new opportunities to accelerate technical advances in power wheelchairs through closer integration of the key control and motor technologies and expect other novel innovations as a result,” Invacare president and CEO Matt Monaghan said.

“Through this transaction, Dynamic Controls’ technology can be combined with Allied Motion’s unique capabilities as a leading electromotive technology company to drive the next horizon of innovation. This will also help accelerate the adoption of healthcare informatics technology, such as MyLinx, and enable our products to continue improving patient care. We are excited about the opportunities this new partnership can bring to both companies.”

Allied Motion president and CEO Richard Warzala added, “The acquisition of Dynamic Controls provides us another building block in becoming one of the world’s motion solutions leaders. We are eager to begin working with the Dynamic Controls team to inspire the development of new and innovative motion control products

We are also looking forward to a mutually beneficial relationship with the Invacare team, by providing products, service and support for Invacare’s powered mobility and respiratory portfolios.”

"Movers & Shakers"
Ra Medical Systems has appointed Will McGuire as CEO.

Andrew Jackson has served as interim CEO since August and will remain as the company’s CFO.

Neuromod Devices announced that it is appointing Florian Elsaesser as its new CCO.

Dexcom has appointed Jereme Sylvain as senior VP of finance and chief accounting officer.

Impulse Dynamics announced that it is appointing Dr. Ishu Rao as its medical director.